The Moat Index
Compare moats, side by side.
Two to four companies, scored on the same five investor questions from their SEC filings — so the comparison is apples to apples. The method is fully public.
SKIN · Healthcare · Shallow moat
Doesn't clear the bar
The returnsOnCapital component abstained: Not enough years of ROIC data to score returns on capital. The other four 20% weights were renormalized over the scored 80%.
| Measure | JRSS | SKIN | APT | IRWD |
|---|---|---|---|---|
| Moat Score (0–100) | 55 (highest) | 55 (highest) | 55 (highest) | 55 (highest) |
| Methodology version | moat-index@3.0.0 | moat-index@3.0.0 | moat-index@3.0.0 | moat-index@3.0.0 |
| Business trend | 30 | 42 (highest) | 23 | 20 |
| Pricing power | 70 | 84 | 57 | 99 (highest) |
| Returns on capital | 96 (highest) | — | 33 | 91 |
| Balance-sheet safety | 55 | 28 | 100 (highest) | 30 |
| Capital allocation | 24 | 67 (highest) | 62 | 33 |
| 85% below value if growth stopped today (largest discount to value if growth stopped today) | No price data | 14% above value if growth stopped today | 117% above value if growth stopped today | |
| Market cap | $1.5M | $93.4M | $49.9M | $605M |
| Moat tier | Shallow moat | Shallow moat | Shallow moat | Shallow moat |
| Filing date | FY2023 | FY2025 | FY2025 | FY2025 |